Mirtazapine Tablet
Product Images NDC 72162-1639

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 72162-1639). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

S:\exranbaxy\san-reg\regulatory\spl\deepa\2020\mrtazapine\20191016_f23631be-c7ae-46e9-b771-a70be17bc9f0\mirtazapine-01.jpg (Mirtazapine 01)

S:\exranbaxy\san-reg\regulatory\spl\deepa\2020\mrtazapine\20191016_f23631be-c7ae-46e9-b771-a70be17bc9f0\mirtazapine-01.jpg (Mirtazapine 01)
Chemical structure of mirtazapine, showing its molecular framework with a bicyclic ring system containing nitrogen atoms and a methyl group attached to one of the nitrogen atoms.*
FDA Label Image

Label (Lbl721621639)

Label (Lbl721621639)
Label for Mirtazapine Tablets, USP 15 mg, oral tablet, relabeled by Bryant Ranch Prepack and manufactured by ALKALOIDA Chemical Company Zrt. The label indicates a package size of 1000 tablets, includes storage instructions (20° to 25°C), safety cautions, and a medication guide URL. It features the NDC number 72162-1639.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.